# The Efficacy and Safety Evaluation of 5G Tele-PCI Using R-OneTM

> **NCT07132255** · NA · ENROLLING_BY_INVITATION · sponsor: **Cathbot (Shanghai) Robot Co., Ltd** · enrollment: 60 (estimated)

## Conditions studied

- Coronary Artery Disease (CAD)
- Percutaneous Coronary Intervention (PCI)

## Interventions

- **DEVICE:** R-One assisted tele-PCI
- **DEVICE:** R-One assisted on-site PCI

## Key facts

- **NCT ID:** NCT07132255
- **Lead sponsor:** Cathbot (Shanghai) Robot Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2024-03-14
- **Primary completion:** 2025-09-30
- **Final completion:** 2026-09-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-08-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07132255

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07132255, "The Efficacy and Safety Evaluation of 5G Tele-PCI Using R-OneTM". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07132255. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*